scholarly journals Developing of a Simple Screening Tool for Opportunistic COPD Case Finding

QJM ◽  
2020 ◽  
Vol 113 (Supplement_1) ◽  
Author(s):  
Y M Mohamed ◽  
S H Sharkawy ◽  
D I Darwish

Abstract Background Under diagnosis of COPD is serious problem in many countries world-wide because there are no generally detection tools available to detect high-risk patients for spirometry, and patients will not go for COPD check-up until a serious issue happens like exacerbation. Objective The aim of the work is trying to assess a new screening tool for early diagnosis of COPD. Patients and Methods The present study was conducted upon 500 subjects during the period from march 2018 to august 2018 who admitted to our chest department or visit our outpatient clinic, employees and visitors to Ain Sham hospitals.All subjects >40yrs who smoker or ex-smoker(≥10pack-years) applied a six variants(age,sex,packed years smoked during life ,dyspnea,chronic phlegmand chronic cohgh)questionnaire modified from PUMA questionnaire Subjects with score ≥5 did spirometry Results 500 subjects shared in the study 497 of them were males ( 99.4% )and 3 were females (.6%). 152of them(30.4%) had score <5 and 348 of them (69.6%)had score ≥5 who did spirometry.152 subjects did not perform spirometry. By spirometry we diagnosed 81(23.3) case COPD (fev1-fvc <.7) out of 348 subjects under gone spirometry and 16.2% of total subjects(500) . Conclusion Modified puma score is a simple and easy screening questionnaire for early detection of COPD cases and spirometry should be done to confirm the diagnosis or rule out.COPD is prevalent in many healthy apparent persons.

1970 ◽  
Vol 22 (1) ◽  
pp. 26-29 ◽  
Author(s):  
H Akthar ◽  
S Sultana ◽  
AH Siddique

A 12 months study was carried out on 226 pregnant high risk patients attending in Rajshahi Medical College Hospital from January 2008 to December 2008. The aim of the study was to identify various type of high risk pregnancies and to determine social and educational status as well as new born conditions of birth. Among the 226 recruited patients 69.5% came from rural area. Among the 69.5% rural high risk patients 63.69% were illiterate. Live born baby in this study was 95.13%. In our study neonatal out come was excellent. Excellent out come was attributed to early diagnosis of high risk pregnancy and suitable intervention both by Obstetrician and Paediatrician. DOI: 10.3329/taj.v22i1.5016 TAJ 2009; 22(1): 26-29


Author(s):  
Alain Kalmar ◽  
Nicky Van Der Vekens ◽  
Henk Vanoverschelde ◽  
Diederik Van Sassenbroeck ◽  
Jan Heerman ◽  
...  

CHEST Journal ◽  
2010 ◽  
Vol 138 (4) ◽  
pp. 241A ◽  
Author(s):  
Peter Boyle ◽  
Derek Weycker ◽  
Anne Khuu ◽  
James R. Jett ◽  
Frank C. Detterbeck ◽  
...  

2016 ◽  
Vol 34 (4_suppl) ◽  
pp. 223-223
Author(s):  
Alexandra Gangi ◽  
Mokenge Peter Malafa ◽  
Jason Klapman

223 Background: Pancreatic cancer (PC) is the 4th leading cause of cancer deaths in the US but is rarely diagnosed at an early curable stage. Early detection of PC will have measurable improved outcomes in affected patients. This study sets out to evaluate if EUS can detect early stage pre-cancerous or cancerous changes in the pancreas of high risk (HR) patients. Methods: After IRB review, a clinical trial (NCT01662609) to evaluate HR patients was opened to accrual. Study subjects met specified inclusion and exclusion criteria as defined by the protocol. Enrolled subjects underwent EUS followed by screening as defined by study protocol: subjects with normal EUS underwent repeat EUS at 1 year; subjects with abnormal EUS underwent fine needle aspiration (FNA) if a mass or cyst was found and measured ≥ 5mm and did not undergo FNA if the lesion measured < 5mm. Those with indeterminate or benign FNA underwent pancreatic CT scan with repeat EUS/FNA at 3 or 6 months respectively. Those with positive FNA were treated appropriately based on findings. Patients with mass/cyst < 5mm underwent repeat EUS/FNA at 3 months. Targeted follow-up is 5 years. Results: Of the 52 subjects accrued thus far, 41 were available for interim analysis. Twenty-seven (67%) subjects had a normal EUS while 14 (34%) subjects had abnormal findings. Two patients had large cysts with FNA consistent with an intraductal papillary mucinous neoplasms (IPMN). These 2 subjects ultimately underwent surgical resection. The 12 remaining subjects had at least 1 subcentimeter lesion and are being routinely screened per the outlined protocol. Conclusions: EUS screening of asymptomatic individuals who are at high risk for pancreatic cancer as defined by our inclusion criteria frequently detects abnormal lesions in the pancreas. These lesions include high risk IPMNs that warrant surgical resection. Our results validate the results of other high risk screening protocols and support the screening of individuals who are at high risk for development of pancreatic cancer. Clinical trial information: NCT01662609.


2016 ◽  
Vol 34 (7_suppl) ◽  
pp. 232-232
Author(s):  
Kerri Slavin ◽  
Robyn Dunbar ◽  
Cheryl Clements ◽  
Margaret Bonawitz ◽  
Joanne McGovern

232 Background: Hospital Acquired Pneumonia (HAP) is a leading cause of prolonged hospitalization in patients. The oncology population is especially susceptible to critical illness related to an immunocompromised state. The purpose of this study was to implement the Massey Bedside Swallowing Screen upon admission to the oncology telemetry unit to detect any deficits that could potentially lead to HAP, in conjunction with strict oral care for identified high risk patients. Methods: The importance of the Massey Bedside Swallowing Screen upon admission and the knowledge that early detection leads to better patient outcomes was educated to the nursing staff. Every patient admitted to the oncology telemetry unit was screened with the Massey Bedside Swallowing Screen. Patients identified as high-risk were placed on nothing-by-mouth (NPO) precaution. A Speech and Swallow Evaluation was ordered to further evaluate the patient. Acutely ill oncology patients unable to perform their own oral care were placed on a strict oral care regimen performed by the nursing staff. The charge nurse audited compliance with this protocol. Results: The pre-intervention phase of the study evaluated January – April 2015 included 1,605 patient days. The data revealed 4 HAPs acquired on the oncology telemetry unit, demonstrating 2.45 incidence/1000 patient days. Post-intervention [May – August 2015] indicated 2 HAPs acquired on the oncology telemetry unit, signifying 1.35 incidence/1000 patient days. With the implementation of the Massey Bedside Swallowing Screen for each patient upon admission, and strict oral care regimen for high-risk patients, the overall incidence of HAP on the unit decreased by 50%. Conclusions: Oncology patients assessed with the Massey Bedside Swallowing Screen upon admission to the oncology telemetry unit were noted to have improved outcomes and lower rates of HAP. Every oncology patient admitted to an acute care unit should have an admission screen in place to evaluate risk for aspiration. Early detection of patients at high-risk for HAP and implementation of interventions to improve oral care in high-risk patients lead to improved patient outcomes through lower incidence of HAP in the acute care setting.


Cancer ◽  
2015 ◽  
Vol 121 (S17) ◽  
pp. 3113-3121 ◽  
Author(s):  
Da-Wei Yang ◽  
Yong Zhang ◽  
Qun-Ying Hong ◽  
Jie Hu ◽  
Chun Li ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document